health.harvard.edu/blog/pro...
The report states that for intermediate-risk men, focal therapy is giving the same outcome at 5 years (that's as far as they have data for..) as having an RP. For high-risk men - maybe not so much.
In both cases, the quality of life is superior with the focal treatments.
Triglycerides and BCR
My treatment decisions
Post biopsy consult. The problem I have with active surveillance.
